Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

GlycoMimetics Cash Flow from Operating Activities 2012-2023 | GLYC

GlycoMimetics cash flow from operating activities from 2012 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
  
GlycoMimetics Annual Cash Flow Ops
(Millions of US $)
2023 $-35
2022 $-46
2021 $-57
2020 $-39
2019 $-52
2018 $-43
2017 $-30
2016 $-30
2015 $-8
2014 $-4
2013 $-16
2012 $-10
2011 $14
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.019B $0.000B
GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.717B 31.19
Chugai Pharmaceutical (CHGCY) Japan $52.344B 23.40
Takeda Pharmaceutical (TAK) Japan $42.314B 8.57
Merck (MKGAF) Germany $21.381B 20.17
Astellas Pharma (ALPMY) Japan $17.916B 28.29
Sandoz Group AG (SDZNY) Switzerland $15.072B 0.00
Shionogi (SGIOY) Japan $14.270B 12.80
Neurocrine Biosciences (NBIX) United States $14.055B 38.47
United Therapeutics (UTHR) United States $11.801B 12.58
Catalent (CTLT) United States $10.131B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.681B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.131B 7.84
Revolution Medicines (RVMD) United States $6.179B 0.00
Ionis Pharmaceuticals (IONS) United States $5.761B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.410B 0.00
Alpine Immune Sciences (ALPN) United States $4.250B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.892B 0.00
Summit Therapeutics (SMMT) United States $3.355B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.063B 0.00
Corcept Therapeutics (CORT) United States $2.769B 25.09
Indivior (INDV) United States $2.464B 11.68
PTC Therapeutics (PTCT) United States $2.381B 0.00
Dyne Therapeutics (DYN) United States $2.268B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.027B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.986B 11.35
NewAmsterdam Pharma (NAMS) Netherlands $1.951B 0.00
Ardelyx (ARDX) United States $1.876B 0.00
Evotec AG (EVO) Germany $1.868B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.849B 17.99
Fusion Pharmaceuticals (FUSN) Canada $1.819B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.90
Soleno Therapeutics (SLNO) United States $1.592B 0.00
Xencor (XNCR) United States $1.451B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.434B 0.00
Pacira BioSciences (PCRX) United States $1.390B 13.21
4D Molecular Therapeutics (FDMT) United States $1.312B 0.00
Collegium Pharmaceutical (COLL) United States $1.238B 7.41
Enliven Therapeutics (ELVN) United States $1.123B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.102B 0.00
Cronos Group (CRON) Canada $1.089B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.055B 16.44
Centessa Pharmaceuticals (CNTA) United Kingdom $0.962B 0.00
Cassava Sciences (SAVA) United States $0.913B 0.00
Ocular Therapeutix (OCUL) United States $0.905B 0.00
USANA Health Sciences (USNA) United States $0.882B 14.43
ARS Pharmaceuticals (SPRY) United States $0.853B 0.00
Relay Therapeutics (RLAY) United States $0.838B 0.00
Sage Therapeutics (SAGE) United States $0.743B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.738B 0.00
Savara (SVRA) United States $0.701B 0.00
Silence Therapeutics (SLN) United Kingdom $0.687B 0.00
Lyell Immunopharma (LYEL) United States $0.683B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.606B 0.00
ProKidney (PROK) United States $0.599B 0.00
Exscientia (EXAI) United Kingdom $0.598B 0.00
Siga Technologies (SIGA) United States $0.551B 7.05
Altimmune (ALT) United States $0.547B 0.00
OmniAb (OABI) United States $0.535B 0.00
Verve Therapeutics (VERV) United States $0.534B 0.00
KalVista Pharmaceuticals (KALV) United States $0.510B 0.00
Larimar Therapeutics (LRMR) United States $0.501B 0.00
Lexeo Therapeutics (LXEO) United States $0.478B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.467B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.460B 0.00
Heron Therapeutics (HRTX) United States $0.443B 0.00
Korro Bio (KRRO) United States $0.440B 0.00
Bioventus (BVS) United States $0.432B 16.55
Tourmaline Bio (TRML) United States $0.404B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Harrow (HROW) United States $0.364B 0.00
Black Diamond Therapeutics (BDTX) United States $0.355B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.333B 0.00
Nanobiotix S.A (NBTX) France $0.314B 0.00
Organogenesis (ORGO) United States $0.301B 57.00
Aquestive Therapeutics (AQST) United States $0.300B 0.00
Fractyl Health (GUTS) United States $0.298B 0.00
Nektar Therapeutics (NKTR) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.293B 18.59
Xeris Biopharma Holdings (XERS) United States $0.279B 0.00
Akebia Therapeutics (AKBA) United States $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.266B 0.00
Metagenomi (MGX) United States $0.258B 0.00
Adherex Technologies (FENC) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.253B 0.00
Eliem Therapeutics (ELYM) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Avita Medical (RCEL) United States $0.225B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Zevra Therapeutics (ZVRA) United States $0.218B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Galectin Therapeutics (GALT) United States $0.201B 0.00
Century Therapeutics (IPSC) United States $0.197B 0.00
Telomir Pharmaceuticals (TELO) United States $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.184B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Prelude Therapeutics (PRLD) United States $0.171B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Incannex Healthcare (IXHL) Australia $0.162B 0.00
Achieve Life Sciences (ACHV) Canada $0.155B 0.00
Cardiol Therapeutics (CRDL) Canada $0.151B 0.00
Regulus Therapeutics (RGLS) United States $0.147B 0.00
CytoDyn (CYDY) United States $0.144B 0.00
Context Therapeutics (CNTX) United States $0.137B 0.00
Elite Pharmaceuticals (ELTP) United States $0.135B 12.63
VAXART, INC (VXRT) United States $0.129B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.129B 8.59
OptiNose (OPTN) United States $0.127B 0.00
Karyopharm Therapeutics (KPTI) United States $0.126B 0.00
FibroGen (FGEN) United States $0.121B 0.00
Relmada Therapeutics (RLMD) United States $0.115B 0.00
Citius Pharmaceuticals (CTXR) United States $0.112B 0.00
PMV Pharmaceuticals (PMVP) United States $0.108B 0.00
Inotiv (NOTV) United States $0.107B 0.00
Assertio Holdings (ASRT) United States $0.100B 4.57
Vivani Medical (VANI) United States $0.095B 0.00
AlloVir (ALVR) United States $0.094B 0.00
ProPhase Labs (PRPH) United States $0.089B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Jaguar Animal Health (JAGX) United States $0.085B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.071B 1.00
Journey Medical (DERM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.063B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.062B 0.00
Protara Therapeutics (TARA) United States $0.061B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
BioLineRx (BLRX) Israel $0.055B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
Nutriband (NTRB) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
DURECT (DRRX) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.025B 0.00
Lyra Therapeutics (LYRA) United States $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
BioVie (BIVI) United States $0.020B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.31
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.76